Balyasny Asset Management’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CPUH.WS
SRCM
PIF
JRCM
PAMP
AC
ETH
TP
SCM
CAC
Balyasny Asset Management's CPUH.WS Position: Q2 2023 in Review
Balyasny Asset Management sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q2 2023, closing a stake of 50,000 shares — an estimated $20K sold.
Balyasny Asset Management first reported a position in CPUH.WS in Q1 2021 and held it in 9 quarters. The position peaked at $76K in Q2 2021. 55 funds tracked by Wall St. Rank hold CPUH.WS as of Q2 2023.
- Balyasny Asset Management reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
- Balyasny Asset Management sold 50,000 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q2 2023, an estimated $20K.
- Balyasny Asset Management first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2021 and held it in 9 quarters.
- Balyasny Asset Management's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $76K in Q2 2021.
- 55 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q2 2023.
Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.